4925 Results

People

  1. Giralt
    Giralt
  2. Berger
    Berger
  3. Morrow
    Morrow
  4. Horwitz
    Horwitz
  5. Ladanyi
    Ladanyi
  6. Lee
    Lee
  7. Adusumilli
    Adusumilli
  8. Hyman
    Hyman
  9. Perales
    Perales
  10. Solit
    Solit

Groups

  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)
  7. Center for Hematologic Malignancies (764)
  8. Hematologic Malignancies, Division of (714)
  9. Department of Pathology and Laboratory Medicine (653)
  10. Population Sciences Research Program (632)
  1. "2017"
Formats
  1. Journal Article (3053)
  2. Meeting Abstract (1581)
  3. Book Section (242)
  4. Conference Paper (35)
  5. Book Whole (12)
  6. Editorial (1)
  7. Review (1)
Groups
  1. Department of Medicine (2037)
  2. GSK Faculty (1130)
  3. Solid Tumor Oncology Division (1105)
  4. Sloan Kettering Institute Postdocs (1022)
  5. Surgery (893)
  6. Survivorship Research (780)

More Groups

People
  1. Sergio Giralt (86)
  2. Jose Baselga (68)
  3. Michael Berger (67)
  4. Monica Morrow (65)
  5. Jedd Wolchok (62)
  6. Martin Tallman (61)

More People

Years
  1. 2017 (4925)
Publications
  1. Journal of Clinical Oncology (349)
  2. Blood (233)
  3. Annals of Oncology (123)
  4. International Journal of Radiation Oncology, Biology, Physics (122)
  5. Modern Pathology (85)
  6. Laboratory Investigation (76)

More Publications

Publishers
  1. Elsevier Inc. (599)
  2. Springer (383)
  3. American Society of Clinical Oncology (378)
  4. Nature Publishing Group (310)
  5. Oxford University Press (280)
  6. American Society of Hematology (246)

More Publishers

Results (4925)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Pazopanib exposure response assessment as adjuvant therapy for patients with localized or locally advanced renal cell carcinoma (RCC) following nephrectomy
    Meeting Abstract

    Sternberg, C. N.; Donskov, F.; Haas, N. B.; Doehn, C.; Russo, P.; Elmeliegy, M.; Banerjee, H.; Aimone, P.; Voi, M.; Motzer, R. J.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase II, open label study of tucatinib (ONT-380) combined with trastuzumab in patients with HER2+ metastatic colorectal cancer (mCRC) (MOUNTAINEER)
    Meeting Abstract

    Strickler, J. H.; Niedzwiecki, D.; Zemla, T.; Cercek, A.; Fakih, M.; Ng, K.; Sanchez, F. A.; Wu, C. S. Y.; Peterson, S.; Bandel, L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Efficacy of vemurafenib in patients (pts) with non-small cell lung cancer (NSCLC) with BRAF(V600) mutation
    Meeting Abstract

    Subbiah, V.; Gervais, R.; Riely, G. J.; Hollebecque, A.; Blay, J. Y.; Felip, E.; Schuler, M. H.; Goncalves, A.; Italiano, A.; Keedy, V. L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Effect of cytarabine/anthracycline/crenolanib induction on minimal residual disease (MRD) in newly diagnosed FLT3 mutant AML
    Meeting Abstract

    Stone, R. M.; Collins, R.; Tallman, M. S.; Walter, R. B.; Karanes, C.; Patel, P. A.; Vusirikala, M.; Coombs, C. C.; Olson, G.; Jain, V. K.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • H3B-8800-G0001-101: A first in human phase I study of a splicing modulator in patients with advanced myeloid malignancies
    Meeting Abstract

    Steensma, D. P.; Maris, M. B.; Yang, J.; Donnellan, W. B.; Brunner, A. M.; McMasters, M.; Greenberg, P.; Komrokji, R. S.; Klimek, V. M.; Goldberg, J. M.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Nomogram to assess survival benefit of new over historical agents as salvage therapy for metastatic urothelial carcinoma (mUC) in non-randomized trials
    Meeting Abstract

    Sonpavde, G.; Pond, G. R.; Rosenberg, J. E.; Choueiri, T. K.; Bellmunt, J.; Regazzi, A. M.; Mullane, S. A.; Necchi, A.; Raggi, D.; Lee, J. L.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • A phase I study of convection enhanced delivery (CED) of (124)I-8H9 radio-labeled monoclonal antibody in children with diffuse intrinsic pontine glioma (DIPG)
    Meeting Abstract

    Souweidane, M. M.; Kramer, K.; Pandit-Taskar, N.; Zanzonico, P.; Zhou, Z.; Donzelli, M.; Lyashchenko, S. K.; Haque, S.; Thakur, S. B.; Cheung, N. K. V.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Relationship of age and cancer treatment to receiving treatment summaries and survivorship care plans in female young adult cancer survivors
    Meeting Abstract

    Shliakhtsitsava, K.; Romero, S. A. D.; Roberts, S.; Su, I.
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Development and validation of a real-world clinicogenomic database
    Meeting Abstract

    Singal, G.; Miller, P. G.; Agarwala, V.; He, J.; Gossai, A.; Frank, S.; Bourque, D.; Bowser, B.; Caron, T.; Baydur, E.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Randomized trial of FOLFOX alone or combined with atezolizumab as adjuvant therapy for patients with stage III colon cancer and deficient DNA mismatch repair or microsatellite instability (ATOMIC, Alliance A021502)
    Meeting Abstract

    Sinicrope, F. A.; Ou, F. S.; Shi, Q.; Nixon, A. B.; Mody, K.; Levasseur, A.; Dueck, A. C.; Dhanarajan, A. R.; Lieu, C. H.; Cohen, D. J.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save